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Background: Aim of this study was to make a comparison between penile cuff test (PCT) and standard pressure-flow
study (PFS) in the preoperative evaluation of patients candidates for trans-urethral resection of prostate (TURP) for
benign prostatic obstruction (BPO).
Methods: We enrolled male patients with lower urinary tract symptoms candidates for TURP. Each of them
underwent a PCT and a subsequent PFS. A statistical analysis was performed: sensitivity (SE), specificity (SP),
positive predictive value (PPV), negative predictive value (NPV), likelihood ratio and ratio of corrected classified
were calculated. Fisher exact test was used to evaluate relationships between PCT and maximal urine flow (Qmax):
a p-value < 0.05 was considered statistically significant.
Results: We enrolled 48 consecutive patients. Overall, at PCT 31 patients were diagnosed as obstructed and 17 patients
as unobstructed. At the subsequent PFS, 21 out of 31 patients diagnosed as obstructed at PCT were confirmed to be
obstructed; one was diagnosed as unobstructed; the remaining 9 patients appeared as equivocal. Concerning the 17
patients unobstructed at PCT, all of them were confirmed not to be obstructed at PFS, with 10 equivocal and
7 unobstructed. The rate of correctly classified patients at PCT was 79% (95%-CI 65%-90%). About detecting
obstructed patients, PCT showed a SE of 100% and a SP of 63%. The PPV was 68%, while the NPV was 100%.
Conclusions: PCT can be an efficient tool in evaluating patients candidates for TURP. In particular, it showed
good reliability in ruling out BPO because of its high NPV, with a high rate of correctly classified patients
overall. Further studies on a huger number of patients are needed, including post-operative follow-up as well.
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resection of prostateBackground
The role of urodynamics (UD) in the diagnosis of benign
prostate obstruction (BPO) has been intensively investi-
gated [1,2].
In clinical practice, when required, a proper evaluation
and quantification of BPO is performed by invasive UD,
in particular pressure-flow study (PFS) [1].
Over the last two decades, some alternative, less inva-
sive tests have been proposed [3], based on equipment* Correspondence: danielebianchimail@yahoo.it
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unless otherwise stated.consisting of an external condom catheter [4], an intra-
urethral device [5] or an inflatable cuff around the penis –
penile cuff test (PCT) – with inflation-deflation cycles [6].
Instead of the direct intravesical sampling used in PFS,
non-invasive UD aims to give information about bladder
pressure by evaluating the equal urine pressure either
along the urethra (in penile cuff ), or at the external me-
atus (in external condom catheter).
In the PCT with inflation-deflation cycles [6], the pres-
sure needed to stop the flow (pcuff ) represents the bladder
isovolumetric pressure (BIP) e.g. the bladder pressure dur-
ing an isovolumetric contraction. This pressure is detected
by a cuff placed around the penis before micturition [6].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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phase, in order to stop urine flow, and then deflated again.
The inflation-deflation cycle is repeated several times dur-
ing a single micturition, thus allowing to correctly assess
BIP (see Figure 1).
PCT results can be plotted on the nomogram proposed
by Griffiths [7] which is designed on a cartesian plane with
maximal urine flow (Qmax) on the x-axis and pcuff on y-
axis, with an ascending straight line, with y-intercept equal
to 80 cm H2O, separating obstructed from non-obstructed
patients.
Recently, a new prototype of PCT has been proposed
[8], using an automatically controlled inflatable cuff which
detects bladder voiding pressure at constant low urine
flow instead of inflation-deflation cycles.
The purpose of this study was to compare the data of
PCT with inflation-deflation cycles with those of a stand-
ard PFS in patients candidates for trans-urethral resection
of prostate (TURP).Figure 1 The principal of the test is similar to bladder pressure meas
has commenced, the cuff is inflated. The cuff pressure required to stop flowMethods
Male patients who previously received indication to undergo
a TURP in our or in a different center were included. Indi-
cation for TURP had been made on referral urologist
opinion, generally on the basis of the presence of lower
urinary tract symptoms (LUTS) and a reduced flow rate,
independently by other aspects as prostate volume and
alpha-blockers effectiveness.
A urine sample for urine culture was collected by spon-
taneous micturition within 7 days before the tests in order
to rule out possible infections. Exclusion criteria were
diabetes mellitus, any neurological disease, use of drugs
impairing bladder contractility or impacting on lower
urinary tract function, an indwelling bladder catheter over
the previous six months, presence of urinary tract infec-
tion, suspect of malignancies.
Approval of the study by Ethics Committee of Policlinico
Tor Vergata was obtained, and all patients signed a written
informed consent to be included. For each patient, weurement. A small cuff is placed around the penis. When micturition
should equal bladder pressure. p iso: Isovolumetric pressure.
Table 1 Results of penile cuff test (PCT) compared with
pressure-flow studies (PFS)







Total 21 27 48
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procedures were conducted by the same urodynamicist.
PCT was performed by Mediplus CT3000 Cuff Machine®,
which allows multiple inflation-deflation cycles during a
single micturition, getting several BIP measurements.
The patients were instructed to perform a micturition
without abdominal straining.
For each inflation cycle we applied the exclusion rules
proposed by Drinnan et al. [9], thus a cycle was immedi-
ately excluded in case of one of the following conditions:
 No flow recovery after cuff deflation, meaning that
the micturition ended during the last cycle, so the
cuff pressure could have been not responsible for
urine flow stop;
 There was an ‘erratic’ flow trace, which could be
related to straining or maybe to contractions by the
pelvic floor or membranous urethra;
 The urine flow was not interrupted at the device
maximum pressure, which is set at 200 cm H2O for
safety reasons. This situation is associated with
highly contractile bladder.
Furthermore, we repeated any test showing a total
bladder volume less than 150 mL.
PFS was performed by a urodynamic equipment
(Life-Tech®, Stafford, TX, USA) with water-filled bladder
catheter and rectal balloon (Life-Tech®, Stafford, TX,
USA), after a filling phase with non-physiological filling
rate (30–50 mL/s).
The examination was conducted according to the Inter-
national Continence Society recommendations [10,11].
PFS data were plotted on the Abrams-Griffiths modified
nomogram [12,13], while PCT results were plotted on the
nomogram proposed by Griffiths [7].
For each of two categories – obstructed versus non-
obstructed – patients were subdivided into two sub-
groups according to their Qmax, with a threshold of 10 mL/s
[14], in order to evaluate if Qmax was able to improve
accuracy.
Sensitivity (SE), specificity (SP), positive predictive value
(PPV), negative predictive value (NPV), likelihood ratio
and ratio of corrected classified were calculated.
In order to assess accuracy of estimated value, 95%
confidence interval (95%-CI) was calculated for SE, SP,
PPV, NPV and ratio of corrected classified.
Fisher exact test was used to evaluate relationships
between PCT and Qmax: a p-value < 0.05 was considered
statistically significant.
Software Stata 13.0 (College Station®, Texas) was used
for all analysis.
Results have been reported according to Standards
for Reporting of Diagnostic accuracy (STARD) flow-
chart [15].The research was carried out in compliance with the
Helsinki Declaration - Ethical Principles for Medical
Research Involving Human Subjects.
Results
We enrolled 48 consecutive male patients – mean age
61.5 ± 13.1 years.
On uroflowmetry, median Qmax was 11.6 mL/s (range
4.0-25.0 mL/s), with a median post-void residual urine
volume (PVR) of 42 mL (range 0–430 mL) detected by
ultrasound scan. PSA mean value was 2.35 ng/mL (range
0.80-4.10 ng/mL).
No adverse events occurred during or after the tests.
Overall, at PCT 31 patients were diagnosed as obstructed
and 17 patients as unobstructed on Griffiths nomogram [7].
On the subsequent PFS, according to Abrams-Griffiths
nomogram [12,13], 21 out of 31 patients diagnosed as
obstructed at PCT were confirmed to be obstructed; one
was diagnosed as unobstructed; the remaining 9 patients
appeared as equivocal.
Concerning the 17 patients unobstructed at PCT, all of
them were confirmed not to be obstructed on PFS, with
10 equivocal and 7 unobstructed (see Table 1 and Figure 2
for STARD flow-chart).
The rate of correctly classified patients at PCT was
79% (95%-CI 65%-90%).
About pressure measurements, overall at PCT we ob-
tained a mean pcuff equal to 133.75 cm H2O (SD 33.45 cm
H2O), while at PFS we had a mean detrusorial pressure at
Qmax flow equal to 52.69 cm H2O (SD 21.94 cm H2O).
Focusing on obstructed patients, at PCT we had a
mean pcuff =157.00 cm H2O (SD 26.83 cm H2O), while
at PFS the mean detrusorial pressure was 74.00 cm H2O
(SD 14.13 cm H2O).
With regard to the further subdivision according to
Qmax, 15 patients out of the 31 obstructed at PCT
showed a Qmax < 10 mL/s, with the other 16 patients
having a Qmax ≥ 10 mL/s.
On the other hand, among the 17 unobstructed pa-
tients on PCT, we had 5 with a Qmax < 10 mL/s and 12
with a Qmax ≥ 10 mL/s.
Patients categorization into subgroups according to
their Qmax greater or less than 10 mL/s did not produce
a further improvement of PCT ability to diagnose BPO
(Fisher exact test, p = 0.2362).
Figure 2 Results according to Standards for Reporting of Diagnostic accuracy (STARD) flow-chart. PCT: Penile Cuff Test. PFS: Pressure-Flow Studies.
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of 100% (95%-CI 84-100%) and a SP of 63% (95%-CI
42-81%), with a positive likelihood ratio of 2.7 (95%-CI
1.65-4.42). The PPV was 68% (95%-CI 49-83%), while the
NPV was 100% (95%-CI 80-100%). Results are summa-
rized in Table 2.
Discussion
Over the last century, a simple evaluation of PVR has
been proposed as an appealing tool for diagnosing BPO.
Nevertheless, a huge PVR may be due to an impaired de-
trusor contractility (IDC) [16]. In fact, it has been pointed
out that up to one half of unobstructed patients with
LUTS could have elevated PVR, while up to one forth of
severely obstructed patients could show no PVR [1].
Thus, the association between elevated PVR and
BPO is not strong enough to be used as a useful clinical
tool [17].
In some papers, the role of uroflow trace has been in-
vestigated as well, but no reliable relation between its
profile and BPO was found out [18].
Some Authors have shown that uroflowmetry could
be able to assess the presence of BPO in the vaste major-
ity of patients with Qmax less than 10 mL/s, with aTable 2 Results of penile cuff test (PCT) compared with press
PCT O PCT U
PFS O (n) PFS U (n) PFS O (n) PFS U (n)
21 10 0 17




n: Number of patients.
SE: Sensitivity.
SP: Specificity.
PPV: Positive Predictive Value.
NPV: Negative predictive Value.
LR+: Positive Likelihood Ratio.progressively decreasing rate of BPO in case of Qmax
major than 10 mL/s [1,2,14].
Accordingly, European Association of Urology guidelines
have considered PFS as an optional test before surgery for
BPO, usually indicated in the preoperative evaluation of
patients showing a Qmax > 15 mL/s [19].
Conversely, 25-30% of men with decreased Qmax at
uroflowmetry are unobstructed [1]. Indeed, decreased
uroflow can result from either impaired detrusor con-
tractility (IDC) or BPO; thus, only detrusor pressure
measurement is able to distinguish between those condi-
tions [18,20].
Furthermore, there are no tips on uroflowmetry trace
shape that allows a distinction between BPO and IDC
[18]; on the other hand, a normal uroflow test does not
rule out BPO [20].
As a consequence, PFS still represents the gold standard
for a proper evaluation of BPO in male patients, above all
when an IDC is suspected [1].
In clinical practice, the nomogram proposed by
Abrams and Griffiths for the diagnosis of obstruction in
males at PFS has been widely used [16].
A further nomogram proposed by Abrams [13] aims
to give a more accurate patients categorization by theure-flow studies (PFS)
SE % SP % PPV % NPV % LR +%
100,0 63,0 67,7 100,0 2,7
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and bladder contractility index (BCI).
Thus, PFS represents the gold standard for the evalu-
ation of BPO [1]. Nevertheless, this test is not used as a
routine examination before surgery for BPO [19], because
it is considered time-consuming, not cost-effective overall
[1] and a potential cause of morbidity [21].
Over the last 30 years, no simple tool proved to be re-
liable in distinguishing between BPO and IDC.
The role of non-invasive UD in clinical practice is still
unclear [19] and few data have been published about
correlation between PCT and PFS findings [6,7,22,23].
Aim of our study was to make a comparison between
PCT and PFS in the diagnostic work-up on patients can-
didates for TURP: summarizing our results, PCT showed
a SE of 100% and a SP of 63% in detecting obstructed
patients, with a PPV of 68% and a NPV of 100%.
Overall, the rate of correctly classified patients at PCT
was 79%. In particular, non-obstructed patients at PCT
were confirmed as non-obstructed at PFS.
Using the nomogram modified for non-invasive pres-
sure measurement, Griffiths et al. [7] obtained with PCT
a PPV of 68% and a NPV of 78% for PFS diagnosis of
BPO. Besides, they noticed that predictive accuracy for
obstruction could be improved by the additional criter-
ion of Qmax less than 10 mL/s, thus obtaining a PPV of
88% and a NPV of 86%.
In our study, patients categorization into subgroups
according to their Qmax (threshold 10 mL/s) did not add
any further information as it did not get confirmation of
its statistical significance at Fisher exact test.
The difference between Griffiths’ and our results could
be due to a different selection of patients: in our study,
only patients who were candidates for a TURP [24] were
enrolled, while in Griffiths’ paper the Authors intended to
analyze patients complaining with LUTS [7]. Nevertheless,
further studies are needed to investigate this aspect.
Our data seem to confirm those ones obtained in an-
other, more recent paper based on 30 consecutive pa-
tients complaining with LUTS. In this study, Borrini L
et al. [22] found for PCT a PPV of 82% and a NPV of
88% for BPO at PFS.
According to our experience, non-invasive UD, in par-
ticular PCT, can be a useful diagnostic tool in patients
candidates for TURP, suggesting a possible solution to
the thorny problem about urodynamic tests before sur-
gery for BPO. In fact, compared to PFS, PCT appeared
as a quick and accurate test to rule out a BPO condition
because of its high NPV. Thus it could be used to run a
selection of non-obstructed patients suspected for an
eventual IDC condition. Indeed, such patients are the
most critical ones in BPO surgery [25], with some papers
reporting about one forth of them showing no symp-
toms improvement after a surgical treatment [24,26].In a paper by Harding et al. [27], a consecutive cohort
of 208 men undergoing TURP were previously evaluated
by PCT: 87% of patients diagnosed with BPO had a clin-
ical improvement after surgery, while only 56% of patients
deemed as not obstructed had a good outcome.
By such diagnostic pathway, non-obstructed patients
(probably with IDC) could be easily recognized and ad-
equately counseled in advance about the prospect of
poor or partial symptoms improvement after surgery for
BPO, avoiding a PFS.
Furthermore, the rate of correctly classified patients at
PCT was high, confirming that most obstructed patients
can be adequately evaluated by PCT.
We should also consider that PCT categorization does
not allow for ‘equivocal’ patients, who finally represent
the mismatch between the two urodynamic tests. Any-
way, those patients can be mostly considered eligible to
surgery, so PFS could be neglected in such cases.
Only patients with an unclear diagnosis could be sug-
gested to undergo PFS, while the other ones could be
probably evaluated just by PCT, getting the amount of
pre-operative information useful both to the surgeon and
to the patient, in terms of preoperative counseling.
Limitations of our study are the relatively small sample
size and the lack of a post-operative follow-up to assess
TURP efficacy in different categories of patients.
On the other hand, this is, to our knowledge, the first
study comparing PCT to PFS in patients candidates for
TURP.
Further papers on large series of patients including
post-operative follow-up are needed, in order to assess
the real role of PCT in the pre-operative evaluation for
BPO.
Conclusions
PCT can be an efficient tool in evaluating patients candi-
dates for TURP. In particular, it showed good reliability
in ruling out BPO because of its high NPV, with a high
rate of correctly classified patients overall. Further studies
based on a bigger sample size are needed, including post-
operative follow-up.Competing interests
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